Use access key #2 to skip to page content.
$20.11 -1.59 (-7.33%)
11/19/2008 4:00 PM

Alnylam Pharmaceuticals, Inc. (ALNY)

CAPS Rating:
***

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

View All Commentary (ALNY)

Recs

1

Avatar nepedal (64.53) Submitted: 5/11/08 6:11 PM : Outperform Start Price: $28.12 ALNY Score: 12.99

amazing science. we'll see if they can get it to work, though

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links